Please login to the form below

Not currently logged in
Email:
Password:

Zydus solidifies Brazilian presence

Indian pharmaceutical company, Zydus Cadila, has purchased a 100 per cent stake in Quimica e Farmaceutica Nikkho do Brasil, a mid-sized, privately held company in Brazil

Indian pharmaceutical company, Zydus Cadila, has purchased a 100 per cent stake in Quimica e Farmaceutica Nikkho do Brasil (Nikkho), a mid-sized, privately held company in Brazil.

The acquisition will boost Zydus' existing generic business in Brazil by providing existing infrastructure. Zydus already has a Brazilian subsidiary, which was set up in 2002, and markets 22 different products under 13 generic brands in the region.

The acquisition is being made through Zydus Healthcare Brasil, a wholly owned subsidiary of Cadila Healthcare. An agreement signed will come into effect after the satisfaction of closing conditions. Financial terms remain undisclosed.

Nikkho posted sales of USD 26m in 2006. The Brazilian pharmaceutical market is the largest in the LATAM region, with a value estimated at approximately USD 8bn.

With the acquisition, Zydus gains an existing manufacturing facility, which will benefit Zydus as Brazilian pharmaceutical regulations will eventually make it mandatory for companies to have a manufacturing base in the region. Zydus already has its own QC lab there.

The Nikkho acquisition is the second so far in 2007. Other recent acquisitions include the 2000 purchase of Recon Healthcare (India 2000), German Remedies (India 2001), Banyan Chemicals (India 2002), Alpharma France (France 2003), Liva Healthcare (India 2003) and Nippon Universal Pharmaceuticals (Japan 2007).

Nikkho's sales force of 125 people covers major markets in Brazil. The company's product range includes those for general medicine, paediatrics, gynaecology, neurology, gasteroenterology, otolaryngology, respiratory products and dermatology.

23rd July 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

The big issue
Whether you want to lead or follow, you need to understand the elephant in the C-suite...
INFOGRAPHIC 02: The Importance of clinical study websites
Here’s a infographic of why clinical study websites are important to patient recruitment and retention strategies…...
Working with, Advocating for, and Empowering Patients
A holistic view of how to work with patients virtually...

Infographics